Bond Market Suggests Fed May Shift to Tightening Bias Under Warsh Leadership Wilson Sonsini Advises Greenhouse on Acquisition of Ezra AI Labs Former SNP Chief Executive Pleads Guilty to Embezzling 400000 in Party Funds Analyst Sumeet Bagadia Highlights Five Stocks for Potential Gains on May 25 The AI Economy Reshapes the American Dream BlueCollar Workers Gain Ground Michael Price Advocates Contrarian Investing to Navigate Market Volatility Capital City Bank Group Q1 2026 Earnings EPS Surpasses Estimates by Over 8 Amid Stable Performance OTLY Q1 2026 Earnings EPS Surprise of 6017 Over Expectations Amid Broader Market Concerns CNF Q4 2023 Earnings EPS Soars Past Estimates with 54356 Surprise BLX Q1 2026 Earnings Earnings Per Share Reported at 131 Shares Dip 227 KEQU Q1 2026 Earnings Profitability Maintained Despite Missing Revenue Disclosure Patrick Industries PATK Q1 2026 Earnings EPS Beat Amid Modest Revenue Disclosure Invest Green Acquisition Corporation Units IGACU Dips 157 as It Tests Support Near 956 XFLT Shares Dip 138 as Floating Rate Income Trust Consolidates Below Resistance Thayer Ventures Acquisition TVAI Holds Steady at 1029 as SPAC Market Watches for Catalyst Chubb Limited CB Holds Above Support After 148 Decline Insurance Sector Stays Defensive Creative Medical Technology Holdings CELZ Edges Higher as Biotech Stock Tests Resistance Vestas Wind Systems Stock Slides on Margin Guidance Concerns SPMC Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Dream Finders Homes DFH Gains 199 Amid Positive Sector Momentum AerCap Holdings AER Q1 2026 Earnings EPS Surges Past Estimates by 4294 Shares Dip Slightly VRDN Q1 2026 Earnings NarrowerthanExpected Loss as Viridian Advances Clinical Pipeline VNO Q1 2026 Earnings EPS Misses as Office Headwinds Persist VSECU Q1 2026 Earnings Strong EPS Beat of 2776 Surprise Shares Dip Slightly SPRO Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Response Allstate Q1 2026 Earnings EPS Soars Past Estimates by 447 Driven by Strong Underwriting AKTS Q1 2026 Earnings EPS Miss as PreRevenue Biotech Advances Pipeline